Feasibility Study of Take-Home LAAM Medication – 3

The purpose of this study is to test therapeutic benefits of take-home LAAM. (1) Do subjects with take-home LAAM availability show increased clinical responsibility over subjects without; (2) Do subjects with take-home LAAM attempt diversion when random recall and other diversion safeguards are used; (3) Does treatment response correlate with background or drug use variables at intake, discharge, or during treatment?

Health authority:

Minimum age for eligibility:

  • 18

Expected total enrollment:

  • 0

Medical trial

ClinicalTrials.gov Identifier:

  • NCT00000300

Sponsor:

Type of trial:

Design:

Primary outcomes:

  • Drug Use
  • Decreased frequency of HIV related behavior
  • Increased prosocial behaviors
  • Retention

Start date:

  • Mar 1995

Phase:

Eligibile genders:

View entire collection »

Eligibility inclusion criteria:

  • Meets DSM-IV criteria for opiate dependence
  • Willing to provide names, addresses, and numbers of 3 relatives who can aid in patient location for follow-up visits
  • Able to understand English
  • Certified for LAAM treatment by a physician

Eligibility exclusion criteria:

  • Hypertensive to LAAM
  • Female of childbearing potential who refuses to use an acceptable form of birth control
  • Pregnant or nursing women
  • Medical or psychiatric illness which would jeopardize safe study participation
  • Clinically significant abnormality in hematology, blood work, or UA, ETOH and/or sedative/hypnotic dependence according to DSM-IV criteria

Location:

Diseases:

Treatment being tested:

top ↑

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!